Free Trial

Edgestream Partners L.P. Invests $3.27 Million in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background
Remove Ads

Edgestream Partners L.P. acquired a new stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 50,935 shares of the company's stock, valued at approximately $3,268,000.

Other hedge funds also recently modified their holdings of the company. State Street Corp increased its holdings in Ryan Specialty by 1.5% in the third quarter. State Street Corp now owns 3,273,093 shares of the company's stock worth $217,301,000 after buying an additional 49,198 shares during the last quarter. Janus Henderson Group PLC lifted its position in Ryan Specialty by 0.4% during the 3rd quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company's stock valued at $209,058,000 after purchasing an additional 13,986 shares during the period. Principal Financial Group Inc. raised its position in shares of Ryan Specialty by 115.2% during the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after acquiring an additional 981,505 shares during the last quarter. Barclays PLC grew its holdings in Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company's stock valued at $108,994,000 after purchasing an additional 17,267 shares during the period. Finally, Raymond James Financial Inc. bought a new position in shares of Ryan Specialty during the fourth quarter worth $94,484,000. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $66.71, for a total transaction of $2,334,850.00. Following the completion of the sale, the director now owns 60,200 shares of the company's stock, valued at approximately $4,015,942. The trade was a 36.76 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders have sold 316,451 shares of company stock worth $20,907,793 in the last ninety days. Insiders own 11.10% of the company's stock.

Remove Ads

Ryan Specialty Stock Up 1.8 %

Shares of Ryan Specialty stock traded up $1.23 during trading hours on Wednesday, reaching $69.41. 1,650,261 shares of the company's stock were exchanged, compared to its average volume of 985,546. The stock has a market cap of $18.17 billion, a P/E ratio of 100.59, a P/E/G ratio of 1.19 and a beta of 0.71. The company has a 50 day moving average of $66.75 and a two-hundred day moving average of $67.66. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a fifty-two week low of $48.48 and a fifty-two week high of $75.97.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date is Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio (DPR) is 69.57%.

Analysts Set New Price Targets

Several research firms have weighed in on RYAN. Morgan Stanley began coverage on Ryan Specialty in a report on Thursday, December 5th. They set an "overweight" rating and a $90.00 target price on the stock. Barclays increased their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a research note on Thursday, November 21st. UBS Group lifted their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Royal Bank of Canada reduced their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a report on Friday, February 21st. Finally, Wells Fargo & Company raised their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $75.27.

View Our Latest Report on Ryan Specialty

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Articles

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads